Intrinsic value of Monsanto - MON

Previous Close

$120.99

  Intrinsic Value

$106.93

stock screener

  Rating & Target

hold

-12%

Previous close

$120.99

 
Intrinsic value

$106.93

 
Up/down potential

-12%

 
Rating

hold

*Intrinsic value change (in %) minus stock price change (in %) in the past 12 months.

We calculate the intrinsic value of MON stock by summing up the current values of future distributable cash flows generated by the company and dividing the sum by the number of outstanding shares. As such, the intrinsic value calculation depends entirely on projections. The more accurate your projections of the company's performance are - the more reliable is the intrinsic value calculation result. Please make sure to check the stock valuation input data below and adjust it if necessary. The quality of the output (intrinsic valuation result) is only as good as the quality of the input. See also DISCLAIMERS.

STOCK VALUATION INPUT DATA

Initial revenue growth rate, %
Terminal revenue growth rate, %
Revenue decline factor
Initial discount rate, %
Discount rate multiplier
Shares outstanding, mln

 

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year
2017(a)
   2018
   2019
   2020
   2021
   2022
   2023
   2024
   2025
   2026
   2027
   2028
   2029
   2030
   2031
   2032
   2033
   2034
   2035
   2036
   2037
   2038
   2039
   2040
   2041
   2042
   2043
   2044
   2045
   2046
   2047

INCOME STATEMENT

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Revenue growth rate, %
  8.43
  4.80
  4.82
  4.84
  4.85
  4.87
  4.88
  4.89
  4.90
  4.91
  4.92
  4.93
  4.94
  4.94
  4.95
  4.95
  4.96
  4.96
  4.97
  4.97
  4.97
  4.98
  4.98
  4.98
  4.98
  4.98
  4.99
  4.99
  4.99
  4.99
  4.99
Revenue, $m
  14,640
  15,343
  16,082
  16,860
  17,679
  18,539
  19,445
  20,396
  21,396
  22,448
  23,553
  24,714
  25,934
  27,216
  28,563
  29,978
  31,465
  33,026
  34,667
  36,390
  38,199
  40,100
  42,096
  44,193
  46,395
  48,707
  51,135
  53,685
  56,364
  59,176
  62,129
Variable operating expenses, $m
 
  4,031
  4,205
  4,389
  4,582
  4,786
  4,999
  5,224
  5,460
  5,708
  5,969
  5,834
  6,122
  6,425
  6,743
  7,077
  7,428
  7,797
  8,184
  8,591
  9,018
  9,467
  9,938
  10,433
  10,953
  11,499
  12,072
  12,674
  13,306
  13,970
  14,667
Fixed operating expenses, $m
 
  7,939
  8,137
  8,341
  8,549
  8,763
  8,982
  9,206
  9,437
  9,672
  9,914
  10,162
  10,416
  10,677
  10,943
  11,217
  11,497
  11,785
  12,080
  12,382
  12,691
  13,008
  13,334
  13,667
  14,009
  14,359
  14,718
  15,086
  15,463
  15,849
  16,246
Total operating expenses, $m
  11,428
  11,970
  12,342
  12,730
  13,131
  13,549
  13,981
  14,430
  14,897
  15,380
  15,883
  15,996
  16,538
  17,102
  17,686
  18,294
  18,925
  19,582
  20,264
  20,973
  21,709
  22,475
  23,272
  24,100
  24,962
  25,858
  26,790
  27,760
  28,769
  29,819
  30,913
Operating income, $m
  3,212
  3,373
  3,740
  4,131
  4,547
  4,991
  5,464
  5,966
  6,500
  7,067
  7,669
  8,718
  9,396
  10,115
  10,877
  11,684
  12,539
  13,445
  14,403
  15,417
  16,490
  17,625
  18,825
  20,093
  21,433
  22,850
  24,346
  25,926
  27,595
  29,356
  31,216
EBITDA, $m
  3,960
  4,270
  4,660
  5,076
  5,519
  5,990
  6,491
  7,024
  7,589
  8,190
  8,828
  9,504
  10,221
  10,981
  11,785
  12,638
  13,540
  14,496
  15,506
  16,575
  17,706
  18,901
  20,164
  21,499
  22,910
  24,399
  25,973
  27,634
  29,388
  31,239
  33,193
Interest expense (income), $m
  417
  355
  388
  423
  459
  498
  538
  581
  625
  672
  722
  773
  828
  885
  945
  1,009
  1,075
  1,145
  1,218
  1,295
  1,376
  1,461
  1,550
  1,644
  1,742
  1,845
  1,954
  2,068
  2,187
  2,313
  2,445
Earnings before tax, $m
  2,886
  3,018
  3,352
  3,708
  4,088
  4,493
  4,925
  5,385
  5,875
  6,395
  6,948
  7,944
  8,568
  9,229
  9,931
  10,676
  11,464
  12,300
  13,185
  14,122
  15,114
  16,164
  17,275
  18,449
  19,691
  21,004
  22,392
  23,858
  25,407
  27,043
  28,771
Tax expense, $m
  626
  815
  905
  1,001
  1,104
  1,213
  1,330
  1,454
  1,586
  1,727
  1,876
  2,145
  2,313
  2,492
  2,681
  2,882
  3,095
  3,321
  3,560
  3,813
  4,081
  4,364
  4,664
  4,981
  5,317
  5,671
  6,046
  6,442
  6,860
  7,302
  7,768
Net income, $m
  2,260
  2,203
  2,447
  2,707
  2,984
  3,280
  3,595
  3,931
  4,288
  4,668
  5,072
  5,799
  6,254
  6,737
  7,250
  7,793
  8,369
  8,979
  9,625
  10,309
  11,034
  11,800
  12,611
  13,468
  14,375
  15,333
  16,346
  17,416
  18,547
  19,742
  21,003

BALANCE SHEET

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cash and short-term investments, $m
  1,958
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Total assets, $m
  21,333
  20,295
  21,273
  22,302
  23,385
  24,523
  25,720
  26,979
  28,302
  29,693
  31,154
  32,690
  34,305
  36,000
  37,782
  39,654
  41,620
  43,686
  45,856
  48,135
  50,528
  53,042
  55,683
  58,456
  61,369
  64,427
  67,639
  71,013
  74,555
  78,275
  82,181
Adjusted assets (=assets-cash), $m
  19,375
  20,295
  21,273
  22,302
  23,385
  24,523
  25,720
  26,979
  28,302
  29,693
  31,154
  32,690
  34,305
  36,000
  37,782
  39,654
  41,620
  43,686
  45,856
  48,135
  50,528
  53,042
  55,683
  58,456
  61,369
  64,427
  67,639
  71,013
  74,555
  78,275
  82,181
Revenue / Adjusted assets
  0.756
  0.756
  0.756
  0.756
  0.756
  0.756
  0.756
  0.756
  0.756
  0.756
  0.756
  0.756
  0.756
  0.756
  0.756
  0.756
  0.756
  0.756
  0.756
  0.756
  0.756
  0.756
  0.756
  0.756
  0.756
  0.756
  0.756
  0.756
  0.756
  0.756
  0.756
Average production assets, $m
  6,655
  6,981
  7,317
  7,671
  8,044
  8,435
  8,847
  9,280
  9,735
  10,214
  10,717
  11,245
  11,800
  12,383
  12,996
  13,640
  14,317
  15,027
  15,773
  16,557
  17,381
  18,246
  19,154
  20,108
  21,110
  22,162
  23,267
  24,427
  25,645
  26,925
  28,269
Working capital, $m
  2,253
  1,227
  1,287
  1,349
  1,414
  1,483
  1,556
  1,632
  1,712
  1,796
  1,884
  1,977
  2,075
  2,177
  2,285
  2,398
  2,517
  2,642
  2,773
  2,911
  3,056
  3,208
  3,368
  3,535
  3,712
  3,897
  4,091
  4,295
  4,509
  4,734
  4,970
Total debt, $m
  8,124
  7,922
  8,631
  9,376
  10,159
  10,984
  11,850
  12,762
  13,720
  14,727
  15,785
  16,897
  18,065
  19,293
  20,583
  21,938
  23,362
  24,858
  26,428
  28,078
  29,811
  31,632
  33,543
  35,551
  37,660
  39,874
  42,200
  44,642
  47,207
  49,900
  52,728
Total liabilities, $m
  14,895
  14,693
  15,402
  16,147
  16,930
  17,755
  18,621
  19,533
  20,491
  21,498
  22,556
  23,668
  24,836
  26,064
  27,354
  28,709
  30,133
  31,629
  33,199
  34,849
  36,582
  38,403
  40,314
  42,322
  44,431
  46,645
  48,971
  51,413
  53,978
  56,671
  59,499
Total equity, $m
  6,438
  5,601
  5,871
  6,155
  6,454
  6,768
  7,099
  7,446
  7,811
  8,195
  8,599
  9,023
  9,468
  9,936
  10,428
  10,944
  11,487
  12,057
  12,656
  13,285
  13,946
  14,640
  15,368
  16,134
  16,938
  17,782
  18,668
  19,599
  20,577
  21,604
  22,682
Total liabilities and equity, $m
  21,333
  20,294
  21,273
  22,302
  23,384
  24,523
  25,720
  26,979
  28,302
  29,693
  31,155
  32,691
  34,304
  36,000
  37,782
  39,653
  41,620
  43,686
  45,855
  48,134
  50,528
  53,043
  55,682
  58,456
  61,369
  64,427
  67,639
  71,012
  74,555
  78,275
  82,181
Debt-to-equity ratio
  1.262
  1.410
  1.470
  1.520
  1.570
  1.620
  1.670
  1.710
  1.760
  1.800
  1.840
  1.870
  1.910
  1.940
  1.970
  2.000
  2.030
  2.060
  2.090
  2.110
  2.140
  2.160
  2.180
  2.200
  2.220
  2.240
  2.260
  2.280
  2.290
  2.310
  2.320
Adjusted equity ratio
  0.231
  0.276
  0.276
  0.276
  0.276
  0.276
  0.276
  0.276
  0.276
  0.276
  0.276
  0.276
  0.276
  0.276
  0.276
  0.276
  0.276
  0.276
  0.276
  0.276
  0.276
  0.276
  0.276
  0.276
  0.276
  0.276
  0.276
  0.276
  0.276
  0.276
  0.276

CASH FLOW

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net income, $m
  2,260
  2,203
  2,447
  2,707
  2,984
  3,280
  3,595
  3,931
  4,288
  4,668
  5,072
  5,799
  6,254
  6,737
  7,250
  7,793
  8,369
  8,979
  9,625
  10,309
  11,034
  11,800
  12,611
  13,468
  14,375
  15,333
  16,346
  17,416
  18,547
  19,742
  21,003
Depreciation, amort., depletion, $m
  748
  897
  921
  945
  971
  999
  1,027
  1,058
  1,090
  1,123
  1,158
  786
  825
  866
  909
  954
  1,001
  1,051
  1,103
  1,158
  1,215
  1,276
  1,339
  1,406
  1,476
  1,550
  1,627
  1,708
  1,793
  1,883
  1,977
Funds from operations, $m
  3,335
  3,100
  3,367
  3,652
  3,956
  4,279
  4,623
  4,989
  5,378
  5,791
  6,230
  6,586
  7,080
  7,603
  8,159
  8,747
  9,370
  10,030
  10,728
  11,467
  12,249
  13,076
  13,950
  14,874
  15,851
  16,883
  17,973
  19,125
  20,341
  21,624
  22,980
Change in working capital, $m
  109
  56
  59
  62
  65
  69
  72
  76
  80
  84
  88
  93
  98
  103
  108
  113
  119
  125
  131
  138
  145
  152
  160
  168
  176
  185
  194
  204
  214
  225
  236
Cash from operations, $m
  3,226
  3,044
  3,308
  3,590
  3,890
  4,210
  4,551
  4,913
  5,298
  5,707
  6,142
  6,493
  6,982
  7,501
  8,051
  8,634
  9,251
  9,905
  10,597
  11,329
  12,104
  12,924
  13,790
  14,706
  15,675
  16,698
  17,779
  18,921
  20,126
  21,399
  22,743
Maintenance CAPEX, $m
  0
  -465
  -488
  -512
  -536
  -563
  -590
  -619
  -649
  -681
  -714
  -749
  -786
  -825
  -866
  -909
  -954
  -1,001
  -1,051
  -1,103
  -1,158
  -1,215
  -1,276
  -1,339
  -1,406
  -1,476
  -1,550
  -1,627
  -1,708
  -1,793
  -1,883
New CAPEX, $m
  -1,311
  -326
  -336
  -354
  -372
  -392
  -412
  -433
  -455
  -478
  -503
  -528
  -555
  -583
  -613
  -644
  -676
  -711
  -746
  -784
  -823
  -865
  -908
  -954
  -1,002
  -1,052
  -1,105
  -1,160
  -1,219
  -1,280
  -1,344
Cash from investing activities, $m
  -1,107
  -791
  -824
  -866
  -908
  -955
  -1,002
  -1,052
  -1,104
  -1,159
  -1,217
  -1,277
  -1,341
  -1,408
  -1,479
  -1,553
  -1,630
  -1,712
  -1,797
  -1,887
  -1,981
  -2,080
  -2,184
  -2,293
  -2,408
  -2,528
  -2,655
  -2,787
  -2,927
  -3,073
  -3,227
Free cash flow, $m
  2,119
  2,252
  2,483
  2,724
  2,981
  3,256
  3,549
  3,861
  4,194
  4,548
  4,925
  5,215
  5,640
  6,092
  6,572
  7,081
  7,621
  8,193
  8,800
  9,442
  10,123
  10,844
  11,606
  12,413
  13,267
  14,170
  15,124
  16,133
  17,200
  18,326
  19,517
Issuance/(repayment) of debt, $m
  -1,095
  668
  708
  745
  784
  824
  867
  911
  958
  1,007
  1,058
  1,112
  1,169
  1,228
  1,290
  1,355
  1,424
  1,495
  1,571
  1,650
  1,733
  1,820
  1,912
  2,008
  2,109
  2,214
  2,326
  2,442
  2,565
  2,693
  2,828
Issuance/(repurchase) of shares, $m
  103
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Cash from financing (excl. dividends), $m  
  -1,018
  668
  708
  745
  784
  824
  867
  911
  958
  1,007
  1,058
  1,112
  1,169
  1,228
  1,290
  1,355
  1,424
  1,495
  1,571
  1,650
  1,733
  1,820
  1,912
  2,008
  2,109
  2,214
  2,326
  2,442
  2,565
  2,693
  2,828
Total cash flow (excl. dividends), $m
  1,128
  2,921
  3,192
  3,469
  3,765
  4,080
  4,416
  4,772
  5,152
  5,555
  5,983
  6,327
  6,809
  7,320
  7,862
  8,436
  9,045
  9,689
  10,371
  11,092
  11,856
  12,664
  13,518
  14,421
  15,375
  16,384
  17,450
  18,575
  19,764
  21,020
  22,345
Retained Cash Flow (-), $m
  -1,904
  -251
  -270
  -284
  -299
  -314
  -330
  -347
  -365
  -384
  -403
  -424
  -445
  -468
  -492
  -517
  -543
  -570
  -599
  -629
  -661
  -694
  -729
  -765
  -804
  -844
  -887
  -931
  -978
  -1,027
  -1,078
Prev. year cash balance distribution, $m
 
  1,088
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Cash flow adjustment, $m
 
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Cash available for distribution, $m
 
  3,757
  2,922
  3,185
  3,466
  3,766
  4,085
  4,425
  4,787
  5,171
  5,580
  5,903
  6,363
  6,852
  7,370
  7,920
  8,502
  9,119
  9,772
  10,463
  11,195
  11,970
  12,789
  13,656
  14,572
  15,540
  16,563
  17,644
  18,787
  19,993
  21,267
Discount rate, %
 
  5.40
  5.67
  5.95
  6.25
  6.56
  6.89
  7.24
  7.60
  7.98
  8.38
  8.80
  9.24
  9.70
  10.18
  10.69
  11.23
  11.79
  12.38
  13.00
  13.65
  14.33
  15.04
  15.80
  16.59
  17.42
  18.29
  19.20
  20.16
  21.17
  22.23
PV of cash for distribution, $m
 
  3,565
  2,616
  2,678
  2,720
  2,740
  2,739
  2,713
  2,664
  2,592
  2,496
  2,335
  2,205
  2,057
  1,896
  1,726
  1,550
  1,372
  1,196
  1,027
  867
  719
  586
  468
  366
  281
  210
  154
  110
  76
  52
Current shareholders' claim on cash, %
  100
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0

Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and digital agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity. Through its Seeds and Genomics segment, the Company produces seed brands, including DEKALB, Asgrow, Deltapine, Seminis and De Ruiter, and it develops biotechnology traits that assist farmers in controlling insects and weeds and digital agriculture to assist farmers in decision-making. The Seeds and Genomics segment offers products, such as Germplasm and Biotechnology traits. Through its Agricultural Productivity segment, the Company manufactures Roundup brand herbicides and other herbicides and provides lawn-and-garden herbicide products for the residential market.

FINANCIAL RATIOS  of  Monsanto (MON)

Valuation Ratios
P/E Ratio 23.5
Price to Sales 3.6
Price to Book 8.3
Price to Tangible Book
Price to Cash Flow 16.5
Price to Free Cash Flow 27.8
Growth Rates
Sales Growth Rate 8.4%
Sales - 3 Yr. Growth Rate %
EPS Growth Rate %
EPS - 3 Yr. Growth Rate %
Capital Spending Gr. Rate 32.2%
Cap. Spend. - 3 Yr. Gr. Rate -1.4%
Financial Strength
Quick Ratio 2
Current Ratio 0.1
LT Debt to Equity 112.7%
Total Debt to Equity 126.2%
Interest Coverage 8
Management Effectiveness
Return On Assets 12.6%
Ret/ On Assets - 3 Yr. Avg. 10.6%
Return On Total Capital 16.1%
Ret/ On T. Cap. - 3 Yr. Avg. 13.2%
Return On Equity 41.2%
Return On Equity - 3 Yr. Avg. 31.8%
Asset Turnover 0.7
Profitability Ratios
Gross Margin 54.2%
Gross Margin - 3 Yr. Avg. 53.6%
EBITDA Margin 27.7%
EBITDA Margin - 3 Yr. Avg. 26.3%
Operating Margin 21.9%
Oper. Margin - 3 Yr. Avg. 21%
Pre-Tax Margin 19.7%
Pre-Tax Margin - 3 Yr. Avg. 18.5%
Net Profit Margin 15.4%
Net Profit Margin - 3 Yr. Avg. 13.6%
Effective Tax Rate 21.7%
Eff/ Tax Rate - 3 Yr. Avg. 28%
Payout Ratio 41.9%

MON stock valuation input parameters

Revenue. Company's revenue (or sales) is always the starting point of any cash flow forecast. In the MON stock intrinsic value calculation we used $14640 million for the last fiscal year's total revenue generated by Monsanto. The default revenue input number comes from 2017 income statement of Monsanto. You may change it if you feel that it should be adjusted for some unusual circumstances that are not expected to be repeated in the future or if you already know (from interim financial statements, for example) that this year's revenue is going to be quite different.

Revenue growth rate. Forecasted future revenue growth rate is the most important input parameter for the intrinsic value calculation. Unlike other input parameters that are reasonably expected to be in line with their historic averages or their historic trends, the revenue growth rate by and large is a wild card: nobody really knows what the company's revenue will be in the future. Of course, the level of unpredictability is different for different industries (utility companies being the most predictable and, thus, less risky).
    We use three input parameters to forecast the revenue growth rate in our MON stock valuation model: a) initial revenue growth rate of 4.8% whose default value is the revenue growth rate in the most recent quarter compared to the quarterly revenue a year ago; b) terminal revenue growth rate of 5% whose default value is chosen to be close to the average nominal (i.e. not adjusted for inflation) GDP growth rate; and c) revenue decline factor of 0.9, which stipulates that revenue growth rate in each forecasted year will be equal to the difference of the revenue growth rate in the preceding year and the terminal revenue growth rate multiplied by this revenue decline factor (with the passage of time the revenue growth rate will be approaching the terminal revenue growth rate, but not quite reaching it - though the difference could be infinitesimally small).
    At the revenue decline factor of 1, the future revenue growth rate is forecasted to be constant and equal to the initial revenue growth rate. The smaller the revenue decline factor, the faster the revenue growth rate will approach the terminal revenue growth.

Discount rate. The discount rate is used for determining the present value of future cash flows: future cash flows are "discounted" as at normal conditions (that translate into positive expected return on investment) one dollar today is worth more than the same dollar in the future. Unlike all other valuation models, we use variable discount rate, i.e. it increases for each consecutive year. This is done to account for higher risk of cash flows coming in further in the future.
    The initial discount rate of 5.4%, whose default value for MON is calculated based on our internal credit rating of Monsanto, is applied to the cash flow expected to be received a year from now (well, actually, to be precise, in the financial year following the base year - the last year for which we have financial statements). For each consecutive year the discount rate is multiplied by the discount rate multiplier of 1.05, e.i. each year it increases by 5%. Feel free to change this number to correspond to your level of risk assessment of Monsanto.
    By the way, it is easy to set the discount rate to be constant (this would make comparison with other valuation models easier): just set the discount rate multiplier equal to 1 and chose the magnitude of the initial discount rate to your liking.

Variable cost ratio is the ratio of variable costs (i.e. costs that fluctuate with fluctuation of the volume of production) to the revenue expressed as a percentage. In the calculation of intrinsic value of MON stock the variable cost ratio is equal to 26.4%.

Fixed operating expenses is just that - expenses that are not dependant on the volume of production. They are set to $7745 million in the base year in the intrinsic value calculation for MON stock. These expenses increase with the level of inflation in subsequent years.

Interest rate on debt is the average all-in rate of interest paid by the company on its debt. It is set at 4.9% for Monsanto.

Corporate tax rate of 27% is the nominal tax rate for Monsanto. In reality, companies find ways to pay much less taxes than that or not to pay them at all.

Cash flow adjustment could be used for any adjustment the investor deems necessary. Most commonly we use this field to account for stock options-related effects in excess of what is reported on the company's income statement. The cash flow adjustment is expressed as a percentage of the revenue, and in the current valuation of the MON stock is equal to 0%.

Production assets are the company's assets used for manufacturing products or provision of services. In the valuation model input table they are expressed as a percentage of revenue and for MON are equal to 45.5%.

Life of production assets of 14.3 years is the average useful life of capital assets used in Monsanto operations. It is used to calculate yearly capital expenditures needed to keep these assets in good order - we call it the maintenance CAPEX.

Working capital is the difference between the company's current assets and liabilities. In the model we use the ratio of working capital to revenue, which for MON is equal to 8%. A negative number means that the company is apt at using financial resources of its suppliers and customers; a large positive number, on the other hand, means that it either provides in-kind financing to others or is not good at managing its inventories.

Book value of equity - $6438 million for Monsanto - is used in calculation of the "floor" for intrinsic valuation based on the discounted cash flow (DCF) method. Even if the prospects are very bad for a company, its assets could always be sold now for their current fair market value.

Shares outstanding of 438.26 million for Monsanto is needed to calculate the intrinsic value of one share.

Market capitalization is used here only for reference purposes and as a quick check that the share price and the number of shares outstanding numbers are correct - something especially to be cognizant about at stock splits. So, the market capitalization of Monsanto at the current share price and the inputted number of shares is $53.0 billion.

RELATED COMPANIES Price Int.Val. Rating
FMC FMC 89.85 2.71  str.sell
SMG Scotts Miracle 106.93 574.29  str.buy
SYT Syngenta ADR 92.90 33.78  str.sell
SEED Origin Agritec 1.16 0.25  str.sell
RKDA Arcadia Biosci 0.300 0.14  str.sell

COMPANY NEWS

▶ Praxairs 4Q17 Revenue Expectations: The Driving Factors   [Jan-18-18 11:35AM  Market Realist]
▶ APD to Acquire Coal Gasification Technology from Shell   [Jan-16-18 09:25AM  Market Realist]
▶ Scotts Miracle-Gro: Ratings and Price Target for January   [Jan-12-18 10:32AM  Market Realist]
▶ Analysts Views on FMC in January 2018   [09:03AM  Market Realist]
▶ Monsanto: Update for Analyst Ratings and Price Target   [Jan-11-18 04:25PM  Market Realist]
▶ RPM Internationals Latest Dividend: All the Key Dates   [Jan-10-18 11:50AM  Market Realist]
▶ What Impact Could a Remade Nafta Have On You?   [Jan-08-18 05:40PM  MarketWatch]
▶ Monsantos 1Q18 Profitability and Outlook   [07:39AM  Market Realist]
▶ Analyzing Monsantos 1Q18 Gross Margin Performance   [Jan-05-18 05:05PM  Market Realist]
▶ How Did Monsantos Sales Perform in 1Q18?   [03:35PM  Market Realist]
▶ Correction: Washington-Monsanto Lawsuit story   [12:52PM  Associated Press]
▶ Correction: Oregon-Monsanto Lawsuit story   [12:51PM  Associated Press]
▶ Monsanto Merger With Bayer Progresses   [12:09PM  GuruFocus.com]
▶ Oregon files $100M suit against Monsanto over PCB contamination   [12:00PM  American City Business Journals]
▶ Monsanto beats 1Q profit forecasts   [04:32PM  Associated Press]
▶ 4 Stocks Swinging on Thursday   [03:53PM  GuruFocus.com]
▶ Monsanto's Q1 profit rises   [08:28AM  Reuters]
▶ Monsantos 1Q18 Earnings: What Analysts Expect   [Dec-28-17 07:33AM  Market Realist]
▶ Analysts Estimates for Monsantos Margin Expansion   [Dec-27-17 03:40PM  Market Realist]
▶ Will Monsanto Sales Growth Fall in 2018?   [02:10PM  Market Realist]
▶ Monsantos 1Q18 Earnings: What to Expect   [12:38PM  Market Realist]
▶ Monsanto: Analyst Recommendations and Earnings Revision   [Dec-15-17 03:25PM  Market Realist]
▶ Minnesota announces restrictions on using herbicide dicamba   [Dec-12-17 10:47PM  Associated Press]
▶ The Bayer-Monsanto Merger Deal: An Update   [09:31AM  Market Realist]
▶ Glassdoor CEO: Here's how to get the highest salary possible   [Dec-06-17 04:23PM  Yahoo Finance Video]
▶ Monsanto moves to stop Arkansas from banning weed killer   [Dec-05-17 07:23PM  Associated Press]
▶ Monsanto Declares Quarterly Dividend   [11:22AM  GuruFocus.com]
Financial statements of MON
Follow us on:   twitter   twitter   twitter   twitter

ASSET ALLOCATION

About X-FIN       Site news       Privacy policy       Terms of use       FAQ

Copyright © X-FIN.com 2005-2018. All rigths reserved.